BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33497973)

  • 1. Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis.
    Gay F; Romeo B; Martelli C; Benyamina A; Hamdani N
    Psychiatry Res; 2021 Mar; 297():113735. PubMed ID: 33497973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.
    Kruse JL; Congdon E; Olmstead R; Njau S; Breen EC; Narr KL; Espinoza R; Irwin MR
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29489077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients.
    Lin CH; Chen MC; Lee WK; Chen CC; Huang CH; Lane HY
    Neuropsychobiology; 2013; 68(2):110-5. PubMed ID: 23881232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-mediated cellular immune activation in electroconvulsive therapy: A CSF study in patients with treatment-resistant depression.
    Mindt S; Neumaier M; Hoyer C; Sartorius A; Kranaster L
    World J Biol Psychiatry; 2020 Feb; 21(2):139-147. PubMed ID: 31081432
    [No Abstract]   [Full Text] [Related]  

  • 5. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review.
    Yrondi A; Sporer M; Péran P; Schmitt L; Arbus C; Sauvaget A
    Brain Stimul; 2018; 11(1):29-51. PubMed ID: 29111078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression.
    Bahji A; Hawken ER; Sepehry AA; Cabrera CA; Vazquez G
    Acta Psychiatr Scand; 2019 Mar; 139(3):214-226. PubMed ID: 30506992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels.
    Rapinesi C; Kotzalidis GD; Curto M; Serata D; Ferri VR; Scatena P; Carbonetti P; Napoletano F; Miele J; Scaccianoce S; Del Casale A; Nicoletti F; Angeletti G; Girardi P
    Psychiatry Res; 2015 Jun; 227(2-3):171-8. PubMed ID: 25910420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of electroconvulsive therapy on plasma levels of neuroactive steroids in inpatients with major depression.
    Turan Ş; Yıldırım A; Aksoy-Poyraz C; Bolayırlı M; Savrun M
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):261-4. PubMed ID: 25000174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pattern of Change in Depressive Symptoms and Inflammatory Markers After Electroconvulsive Therapy: A Systematic Review.
    Desfossés CY; Peredo R; Chabot A; Carmel JP; Tremblay PM; Mérette C; Picher G; Lachance I; Patry S; Lemasson M
    J ECT; 2021 Dec; 37(4):291-297. PubMed ID: 34294652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
    Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
    J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: delayed response after electroconvulsive therapy in a patient with major depressive disorder.
    Chen F; Sidhom E; Yang S; Ruiz-Mendoza E; Essem J
    BMC Psychiatry; 2021 Jan; 21(1):50. PubMed ID: 33478427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors related to acute electroconvulsive therapy outcome for patients with major depressive disorder.
    Chen CC; Lin CH; Yang WC; Chen MC
    Int Clin Psychopharmacol; 2017 May; 32(3):127-134. PubMed ID: 28177952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression.
    Kranaster L; Hoyer C; Aksay SS; Bumb JM; Müller N; Zill P; Schwarz MJ; Sartorius A
    World J Biol Psychiatry; 2018 Aug; 19(5):379-389. PubMed ID: 28714751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder.
    Rovers JJE; Vissers P; Loef D; van Waarde JA; Verdijk JPAJ; Broekman BFP; Vergouwen ACM; Oudega ML; van Exel E; Coenen R; Everaerd DS; Tendolkar I; Dols A; van Eijndhoven PFP
    Acta Psychiatr Scand; 2023 Jun; 147(6):570-580. PubMed ID: 37020420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.
    Rush G; O'Donovan A; Nagle L; Conway C; McCrohan A; O'Farrelly C; Lucey JV; Malone KM
    J Affect Disord; 2016 Nov; 205():60-68. PubMed ID: 27414954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(5):1-66. PubMed ID: 27099642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epinephrine levels decrease in responders after electroconvulsive therapy.
    Pollak C; Maier HB; Moschny N; Jahn K; Bleich S; Frieling H; Neyazi A
    J Neural Transm (Vienna); 2021 Dec; 128(12):1917-1921. PubMed ID: 34554316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pramipexole and Electroconvulsive Therapy in Treatment-Resistant Depression.
    Gauthier C; Souaiby L; Advenier-Iakovlev E; Gaillard R
    Clin Neuropharmacol; 2017; 40(6):264-267. PubMed ID: 29059135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.